NewsRoom Articles - Page 115 of 591

MondayMar 20, 2023 4:20 am

420 with CNW — Bill Targeting Illicit Marijuana Grows Designed to Safeguard Users from Pesticides

A bipartisan pair of congressional lawmakers has refiled a draft law meant to address the growing problem of illicit cannabis plantations on federal land. The lawmakers framed the legislation as a much-needed tool for the government to rein in illegal cannabis grows that are polluting the environment and risking marijuana consumers’ health. Although dozens of states have launched medical and recreational cannabis markets, America’s illicit cannabis market is still thriving. Licensed sellers struggle to compete with the illicit market as high taxes, and rigid rules have made legal cannabis several times more expensive than black-market marijuana. As a result, the…

FridayMar 17, 2023 4:20 pm

420 with CNW — Congressional Lawmakers Want Cannabis Scheduling Review More Transparent

On March 9, 2023, a group of nonpartisan Congress legislators penned a letter to senior Biden administration figures asking for transparency on the president's ongoing review of marijuana's legalization. A draft of the letter was recently distributed by Rep. Earl Blumenauer (D-OR) among Congress for signatures before being sent to Xavier Becerra, secretary of Health and Human Services (HHS), and Merrick Garland, United States attorney general. According to the letter’s content, Biden's scheduling directive presents a chance to evaluate the causes and effects of federal law in an open-minded manner. It also states that cannabis scheduling was based on prejudice…

FridayMar 17, 2023 4:20 am

420 with CNW — Bipartisan Legislators File Bill Allowing Those with Drug Convictions Access to Hemp Industry

Bipartisan congressional legislators have filed a new measure to end the "discriminatory" federal rule that prevents people with prior felonies for drug offenses from owning or operating legal hemp businesses. The "Free to Grow Act," sponsored by Representatives Chellie Pingree (D-ME), David Trone (D-MD), Nancy Mace (R-SC) and Dave Joyce (R-OH), focuses only on the section of the 2018 Farm Bill that dealt with prior convictions and federal legalized hemp. Pingree stated that in spite of legalization, the industry's expansion is being hampered by bureaucracy, regulatory uncertainty and discriminatory policy. Congress is expected to approve a new farm bill version…

ThursdayMar 16, 2023 4:20 pm

420 with CNW — DOJ Appeals Federal Ruling on Gun Rights for Marijuana Users

The U.S. Department of Justice is appealing a recent ruling by Federal Judge Patrick Wyrick that deemed it unconstitutional to prevent people who use state-legal marijuana from using guns. The Justice Department revealed in a filing to the Western District of Oklahoma U.S. District Court that it would appeal the ruling at the U.S. Court of Appeals for the Tenth Circuit. The appeal announcement by the U.S. government comes just a month after Wyrick’s landmark ruling. Although the two-page filing doesn’t elaborate on the arguments behind the ban, U.S. Attorney Robert Troester and Assistant U.S. Attorney David McCray will flesh…

ThursdayMar 16, 2023 4:20 am

420 with CNW — Cannabis Advocates Pin Hopes on Delaware, Hawaii After Ballot Defeat in Oklahoma

Oklahoma voters recently rejected a measure that would have legalized recreational cannabis in the state and expanded access to adults aged 21 and older. With this decision, Oklahoma joined a group of conservative states that have recently rejected measures to legalize adult-use cannabis, including North Dakota, Arkansas and South Dakota. The recreational marijuana measure’s failure to pass in Oklahoma was a blow to advocates, who were hoping that changing attitudes among younger voters coupled with laissez-faire economic attitudes would swing the vote in favor of cannabis. Even though 10% of Oklahomans currently hold a medical cannabis card, 63% of voters…

WednesdayMar 15, 2023 4:20 pm

420 with CNW — Pharmacologist Highlights Untapped Potential in Several Cannabinoids

Medical cannabis dispensaries have a growing selection of products for anxiety, pain, sex and other conditions, with many available strains having magical and evocative names such as Bubba Kush, Blue Dream and Chocolope. But what exactly does this mean? Do the various strains' medical properties differ from one another? Or are the creative names merely marketing ploys? Cannabis is not just a source of cannabinoids, as several studies have shown. The plants is an especially abundant source of therapeutic substances that humans have not yet fully explored. But to fully utilize the plant’s potential, society must move past its prejudices…

WednesdayMar 15, 2023 4:20 am

420 with CNW — More Companies Stop Preemployment Marijuana Tests as Legalization Spreads

Employers are opting to do away with drug screening tests amid a major labor shortage that has caused a deficit of around 3.5 million workers in the workforce. The transportation industry has been especially affected by the labor shortage, with employers in the sector struggling to find enough warehouse personnel, public transit workers, couriers and truck drivers. The food and hospitality industries as well as health care and retail trade have also been grappling with worker shortages for a while. Some companies are now choosing to stop marijuana screening tests for new potential employees as they can reduce the worker…

TuesdayMar 14, 2023 4:20 pm

420 with CNW — California Kickstarts $20M Grant Initiative to Boost Marijuana Retail Sales

California’s Cannabis Control Department (DCC) launched a $20 million grant program to help local governments increase consumer access to legal marijuana products. The Local Jurisdiction Retail Access Grant, which is being hailed as the first program of its kind in the country, aims to give local governments the tools they need to increase access to cannabis products in marginalized areas. According to the department, the grant program will make use of current licensing and permitting procedures to create and implement marijuana retail licensing programs in regions of California where cannabis use is prevalent, but consumers have little to no access…

TuesdayMar 14, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Encouraged by Positive Findings from its DIAB-A22-1 Animal Model Study on Potential DehydraTECH-CBD(TM) Treatment for Diabetes

Lexaria’s DIAB-A22-1 animal model study just concluded, highlighting three positive outcomes, including an improvement in general activity, significant reductions in body weight, and improved triglyceride and cholesterol levels The study was undertaken by a third-party testing laboratory in Canada involving 24 obese and eight lean rats for a total of 32 male Zucker rats The success of this DIAB-A22-1 study marks a significant milestone for Lexaria, even as it continues to explore its patented DehydraTECH(TM) technology application in various other areas, including nicotine replacement, epilepsy, hypertension, dementia and more With its unique product offering, a growing list of patents, and…

TuesdayMar 14, 2023 4:20 am

420 with CNW — Pittcon Research Could Help Regulate Levels of Synthetic and Natural Cannabinoids

Psychedelics and cannabis are probably two of the most common psychoactive drugs, or substances that change physiological and psychological functions. These drugs can affect daily life in both negative and positive ways when used. For instance, when administered correctly, cannabis may be used as a therapeutic option for a range of neurological conditions such as Alzheimer's, Parkinson's and brain cancer. Contrarily, recreational cannabis has been linked to issues with mood, cognition and other symptoms. Cannabinoids, which are naturally occurring substances in the marijuana plant, are what cause the drug's psychological and physical side effects. The most popular cannabinoids are tetrahydrocannabinol…

News and publishing service for cannabis related companies

Contact us: 512.354.7000